GNCP - GNCC Capital, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0001
0.0000 (0.00%)
At close: 3:55PM EDT
Stock chart is not supported by your current browser
Previous Close0.0001
Open0.0002
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0001 - 0.0002
52 Week Range0.0000 - 0.0006
Volume3,200,010
Avg. Volume62,817,013
Market Cap20,313
Beta (3Y Monthly)-0.12
PE Ratio (TTM)N/A
EPS (TTM)-0.0060
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire

    GNCC Capital, Inc. -- Corporate Actions Demanded By Majority Of Company's Shareholders

    LAS VEGAS, Aug. 21, 2019 /PRNewswire/ -- GNCC Capital, Inc. (GNCP.PK) ("The Company" or "GNCC") confirms that it is now in very advanced negotiations which will now result in an immediate and radical restructuring, including replacing the Company's Board of Directors. The Company's Directors, early last week, were approached by a number of shareholders holding secured shares of the Company's Preferred Stock that have now insisted upon immediate changes at the Company.

  • PR Newswire

    GNCC Capital, Inc. Confirms Negotiations With South African Cannabis Cultivator And Exporter

    The GNCC Directors wish to stress that our not divulging any additional information today is that we deem it not to be in the best interests of our shareholders. Specifically, given our need to consummate this transaction(s) without any third party(s) interference.

  • PR Newswire

    GNCC Capital, Inc. Updates On Various Key Transactions

    This Quarterly Report will include the OTC Markets Disclosure Statement. As announced previously, post our becoming PINK CURRENT on the OTC Markets, we are expecting to complete our due diligence as early as tomorrow on a Licensing Agreement on "cutting edge technology" as is required in the Cannabis Sector and it will only conduct business in Canada.

  • PR Newswire

    GNCC Capital, Inc. Cautions Shareholders On Potential Material Events

    LAS VEGAS, June 19, 2019 /PRNewswire/ -- GNCC Capital, Inc. (GNCP) ("The Company" or "GNCC") confirms that they complied with the new OTC Disclosure Rules and filed each and every outstanding Annual and Quarterly Report complete with the "Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines". A total of 18 Reports and two Attorney Letters were filed due to additional information requested by the OTC Markets Compliance Division following their review. The Company was restored last week to that of "PINK CURRENT" on the OTC Markets.

  • PR Newswire

    GNCC Capital, Inc. Addresses Key Issues

    LAS VEGAS, April 16, 2019 /PRNewswire/ -- GNCC Capital, Inc. (GNCP) ("The Company" or "GNCC") has received a number of requests for clarification on various subjects. Only options that deliver value to our shareholders are under consideration. Once a decision has been reached, it will be communicated to our shareholders immediately.

  • PR Newswire

    GNCC Capital, Inc. Updates On Various Matters

    The outgoing Directors of GNCC have agreed to remain and not to depart on March 31, 2019, thereby extending the "transition period" for another month. This is to afford them the time to secure a fair and equitable transaction relating to the Company's Mining Exploration Property portfolio and to complete all of the outstanding Quarterly and Annual Reports. It is imperative that GNCC be restored to a "Current Filer" on the OTC Markets.

  • PR Newswire

    GNCC Capital, Inc. Updates On Its Recently Acquired Colombian Cannabis Company

    LAS VEGAS, March 18, 2019 /PRNewswire/ -- GNCC Capital, Inc. (GNCP) ("The Company" or "GNCC") announced on February 21, 2019 that it had completed the acquisition of BioCann Pharma S.A.S. ("BioCann"), a Cannabis CBD Pharmaceutical Grade Oils Producer and Distributor, incorporated in and operating in the Republic of Colombia ("Colombia") and with offices in Ontario, Canada. Further to that announcement, we confirm that BioCann has appointed their first Director, Paula Andrea Victoria to the GNCC Board on March 6, 2019, a link to this appointment: https://backend.otcmarkets.com/otcapi/company/financial-report/213059/content. The outgoing Directors of GNCC depart on March 31, 2019, being the close of the "transition period".

  • PR Newswire

    GNCC Capital, Inc. Acquires BioCann Pharma S.A.S.

    LAS VEGAS, Feb. 21, 2019 /PRNewswire/ -- GNCC Capital, Inc. (GNCP) ("The Company" or "GNCC") announces that it has acquired a 100% interest in BioCann Pharma S.A.S. ("BioCann"), a Cannabis CBD Pharmaceutical Grade Oils Producer and Distributor, incorporated in and operating in the Republic of Colombia ("Colombia") and with offices in Burlington, Ontario, Canada. BioCann sources the Cannabis a/k/a Biomass from Licensed Growers in Colombia and in the Cundinamarca, Valle del Cauca and Antioquia regions and from those whom grow the strains with the highest quality standard as is required by BioCann.

  • PR Newswire

    GNCC Capital, Inc. Commences Implementation Of Joint Venture

    This Joint Venture was designed to equally benefit the Shareholders of both GNCC and our Joint Venture Partner. It is with great pleasure that we are able to confirm that we are now in a position to implement this Joint Venture after innumerable delays in this process. The Joint Venture Agreement will initially be focused on adding value through exploration work on the following of the Company's Mining Exploration Properties, namely: "Tonopah / East Belmont", "Pearl Spring", "White Hills", "McCracken" and "Yarber Wash".